Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06835647 · ClinicalTrials.gov registry record · NA
Maternal Fetal Device Performance Twins
A NA study of Pregnancy, sponsored by GE Healthcare.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06835647: Recruiting NA study of Pregnancy, sponsored by GE Healthcare.
NCT06835647 is a NA study of Pregnancy that is actively recruiting participants, run by GE Healthcare. The registered enrollment target is 15 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06835647, a NA study of Pregnancy, is actively recruiting participants, sponsored by GE Healthcare.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Maternal Fetal Monitoring devices assist the health care professional in acquiring, monitoring, and storing fetal and maternal physiologic data which support clinical decision making for pregnant women and assesses the overall fetal health status during pregnancy and delivery. This study aims to support a new maternal fetal monitoring device with clinical data by collecting simultaneous, continuous, external, distinguishable FHRs from twin pregnancies using ultrasound Doppler transducers from the new maternal fetal monitoring investigational device and a marketed ultrasound imaging device.
Primary Outcome
Collection of simultaneous, distinct fetal heart rate from SpO2 data from one investigational device over a 40 minutes of continuous fetal monitoring.
Conditions Studied
Interventions
- DEVICE Investigational Fetal Monitor
- DEVICE Ultrasound Imaging Device
Study Locations (1)
Colorado
- Element Materials Technology - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-01-21 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT06835647 shows while recruiting
NCT06835647 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Investigational Fetal Monitor is the first listed.
NCT06835647 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06835647 about?
NCT06835647 is a clinical study titled "Maternal Fetal Device Performance Twins". Maternal Fetal Monitoring devices assist the health care professional in acquiring, monitoring, and storing fetal and maternal physiologic data which support clinical decision making for pregnant women and assesses the overall fetal health status during pregnancy and delivery. This study aims to sup...
What is the current status of trial NCT06835647?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-01-21. Estimated completion is 2025-12-31.
What conditions does trial NCT06835647 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT06835647?
The interventions under investigation include: Investigational Fetal Monitor (DEVICE), Ultrasound Imaging Device (DEVICE).
Who is sponsoring clinical trial NCT06835647?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06835647 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06835647's enrollment target sits among peer trials
15 185th of 191 higher than 4 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI